KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 0.19%.

  • Gilead Sciences' Return on Invested Capital rose 1800.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.02% for FY2024, which is 1100.0% down from last year.
  • Per Gilead Sciences' latest filing, its Return on Invested Capital stood at 0.19% for Q3 2025, which was up 1800.0% from 0.16% recorded in Q2 2025.
  • Gilead Sciences' 5-year Return on Invested Capital high stood at 0.19% for Q3 2025, and its period low was 0.01% during Q3 2024.
  • For the 5-year period, Gilead Sciences' Return on Invested Capital averaged around 0.11%, with its median value being 0.13% (2023).
  • In the last 5 years, Gilead Sciences' Return on Invested Capital plummeted by -1300bps in 2024 and then skyrocketed by 1800bps in 2025.
  • Gilead Sciences' Return on Invested Capital (Quarter) stood at 0.15% in 2021, then dropped by -19bps to 0.12% in 2022, then grew by 6bps to 0.13% in 2023, then tumbled by -80bps to 0.03% in 2024, then skyrocketed by 618bps to 0.19% in 2025.
  • Its Return on Invested Capital was 0.19% in Q3 2025, compared to 0.16% in Q2 2025 and 0.16% in Q1 2025.